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Abstract 
The occurrence and spread of antibiotic-resistant genes (ARGs) are pressing 
public health problems worldwide. A key factor contributing to the spread of ARGs 
is lateral gene transfer. Wastewater treatment plants (WWTPs) are measured hot 
spots of microbial diversity and resistance because they receive polluted 
wastewater from diverse sources and contain a variety of different environments 
with dense bacterial loads. Due to the overuse of antibiotics the genetic capacities 
of microbes have profited. This helps every source of resistance gene and every 
means of horizontal gene transmission to develop the multiple mechanism of 
resistance to each antibiotic used clinically, agriculturally, or by any other medium. 
In wastewater treatment plants, where gastrointestinal wastes from city residents 
co-mingle, the probability for lateral gene transfer events is greatly increased. In 
this study, we use PCR technique to detect four beta-lactamase loci to assess the 
prevalence of ARGs. Wastewater samples from municipal plant at different stages 
of treatment as well as water samples from the river upstream and downstream 
from the release site were collected, followed by total DNA extraction and 
purification. These were then used as templates in PCR-based detection of beta­
lactamase (bla) resistance loci. Our results showed the presence of four loci 
(blaKPC, blaTEM, blaSHV,blaAMPC) in influx, secondary treatment wastewater 
but not in the efflux, nor in the river water samples. Up to now we can say there is 
no detectable levels of ARGs in WWTP effluent samples, upstream and the 
downstream rivers. These data are vital in understanding the role of WWTPs in 
contributing to the spread of antibiotic resistance in the environment. 
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1 .  Introduction 
Over the past several decades, antibiotic-resistant bacterial infections have 
become gradually more prevalent, increasing morbidity and mortality as well as 
the cost of treatment to the patients ( 1 -2]. The incidence and spread of antibiotic­
resistant bacteria (ARB) are persistent public health problems globally, and aquatic 
ecologies are a recognized reservoir for antibiotic resistant bacteria and antibiotic 
resistance genes (ARGs) [3]. Naturally occurring ARGs and antibiotic-resistant 
bacteria in the water are selected for and supplemented for by antibiotics found in 
sewage and agricultural environments, which is a result of the increase in the use 
of antibiotics (3). The increasing interest in the international community and many 
other research organizations in ARGs persisting in the environment is due to the 
high prevalence and incidence of the ARGs report published by many research 
organizations and individuals. Spread of the antibiotic resistant gene in the 
environment can be studied in different ways including the culture and molecular 
methods. When the wastewater from individual homes, agricultural farms, 
hospitals and industrial facilities carrying different microbial human gastrointestinal 
flora drains directly to the wastewater treatment plant, there will be a high load of 
microbial flora in the mixture. These microbial populations contain different variants 
carrying the antibiotic resistant genetic markers, thus enabling lateral gene transfer 
that helps to spread the antibiotic resistant. Untreated water from the wastewater, 
local stream, ponds, rivers are the common places that may have combination of 
different microorganisms' load which can be useful to identify the resistant gene in 
vitro [4]. Advanced treatment technologies in the wastewater and surface water 
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and different disinfection process are regarded as main tool to control the spread 
of antibiotic resistant gene into the environment. Despite these hard efforts made 
over the last years to bring solutions to control antibiotic resistance spread in the 
environment, there are still vital gaps to fill in. Investigating the prevalence and 
incidence of antibiotic resistant loci in the environmental sample is one of the main 
steps in determining and monitoring the spreading of ARGs via wastewater [4-5]. 
Sewage from hospital, followed by municipal, agricultural, and aquatic wastewater 
are shown to be important sources of these many resistant genes and resistant 
bacteria in the environment [6]. 
1 . 1 .  Wastewater treatment plant and process. 
Wastewater is used water which can also an important resource of water, 
particularly with periodic droughts and water shortages in many areas of the world. 
However, wastewater contains many harmful substances that directly or indirectly 
impact humans and animals around the globe. Therefore, wastewater cannot be 
released back into the environment until it is treated. Treating wastewater fulfills 
two important purposes: to restore the water supply and to protect the planet from 
toxins and harmful microorganisms. In the process, microbial organisms are 
indispensable, because they consume the useable carbon, nitrogen, and other 
nutrients from the wastewater. The varying metabolic capacities from different 
microbes are employed at different stages of the process to achieve the final 
objective of purifying wastewater. 
The basic purpose of wastewater treatment is to speed up the natural procedures 
by which water is purified through variety of methods. Once, it is collected through 
the local pipes collected the municipal treatment of wastes begins. Wastewater 
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travels through the pipes by gravity and sometimes pipes get too deep, which 
require a pumper lift station to move wastewater to a new section of pipes 
depending on gravity again [7]. In the primary stage, solids can settle and be 
removed from wastewater. In the secondary stage, biological courses are used to 
further purify wastewater [8]. According to the United States Environmental 
Protection Agency (US EPA), there are about 800,000 miles of collection systems 
along with 500,000 miles of private laterals which connect properties to wastewater 
treatment plants. Treatment facilities in the United States process about 34 billion 
gallons of wastewater every day [9]. 
Typically, following the primary treatment which eliminates the large floating 
objects such as rags and sticks that might clog pipes or damage equipment, 
wastewater is then transferred into a grit chamber, where cinders, sand, and small 
stones settle to the bottom. After screening is finalized and grit has been removed, 
sewage will encompass organic and inorganic matter laterally with other 
suspended solids. These solids are very tiny particles that can be removed from 
sewage in a sedimentation tank. When the speed of the flow through one of these 
tanks is lowered, the suspended solids will initially sink to the bottom, where they 
form a mass of solids called raw primary biosolids or sludge. Biosolids are usually 
removed from tanks and even these can be used as a fertilizer [10-1 1 ] .  
The secondary phase of treatment removes about 85 percent of the organic matter 
in sewage by employing microbes. The main secondary treatment methods used 
in secondary treatment are the dripping filter and the activated sludge process. 
After effluent passes from the sedimentation tank in the primary stage it flows or is 
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pumped to a facility using one or the other of these processes. After secondary 
treatment where activated sludge is digested by the microbes to remove dissolved 
carbons, the wastewater is further treated to remove dissolved nitrogen and sulfur, 
as needed. Following that, part of the sample may be sent to anaerobic digester 
for further processing. Samples are then allowed to sediment and clarify. At this 
point, chlorination or UV treatment may be employed, prior to discharging the water 
back into the environment. 
A successful treatment of wastewater will achieve two goals: To remove potential 
pathogens, and to remove dissolved organic molecules so we do not cause 
eutrophication of the aquatic systems. 
1 .2. Antibiotic resistance beta-lactam 
The modern age of antibiotics began with the discovery of penicil l in, which is a 
member of the class of antibiotic compounds known as beta-lactams by Sir 
Alexander Fleming in 1 928(14-15]. Subsequently, antibiotics have improved 
modern medicine and saved millions of lives [figure 1 ]  [16-17]. Since then, new 
beta-lactam antibiotics were discovered, developed, and deployed[18-19]. In the 
recent years, beta-lactam antibiotic has become the greatest commonly used 
antibiotic. Beta-lactams is the most prescribed for injectable antibiotics(65%) in the 
United States[Figure 2] [20]. The most common forms of beta-lactam drugs are 
penicillin's, cephalosporins, and monobactams. 
These drugs are prescribed to cure illness caused by bacterial infections, such as 
diarrhea, hypersensitivity, nausea, rash, neurotoxicity and urticaria. Despite the 
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benefits, the day-by-day increases in consumption of antibiotics has now rendered 
the resistance to antibiotics one of the major global public health threats. The very 
first antibiotic penicillin resistance became a considerable clinical problem by the 
1 950s and other infections [18-21]. Unfortunately, resistance has eventually been 
seen to nearly all antibiotics that have been developed (Figure 2) l231. 
The structure of most bacteria consists of cell membrane surrounded by cell wall. 
The bacterial cell wall is a flexible macromolecule protecting the bacterium, 
enabling it to resist lysis caused by high intracellular osmotic pressure. Bacterial 
cell walls are made of glycan strands linked together to obtain a polymer called 
peptidoglycan. Peptidoglycan consists of two alternating saccharides, N-acetyl 
glucosamine (GlcNAc, NAG) and N-acetyl muramic acid (MurNA, NAM). These 
two components are cross-linked by short chains of amino acids. In the process of 
cross-linking of the amino acid chains, two enzymes are involved in this process: 
0-alanyl carboxypeptidase and transpeptidase. These are sometimes known as 
penicillin binding proteins (PBPs), and they are the targets for beta-lactam 
antibiotics. There are two types of PBPs: aPBPs and bPBPs.[24-26,42]. aPBPs 
are bifunctional and possess both glycosyltransferase (GT) activity for 
polymerizing the glycan strands and transpeptidase (TP) activity for crosslinking 
them. bPBPs, on the other hand, are only known to possess TP activity. The 
primary target of beta-lactams is the TP active site of the synthetic PBPs, which is 
covalently modified by the drug[27]. The function of beta-lactam antibiotics is to 
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bind the PBPs that crosslink peptidoglycan and prevent the bacterial cell wall 
synthesis. Thus, the cell wall becomes weakened and breaks 
easily due to high intracellular osmotic pressure (figure 3) [29). 
Figure 1 :  The percentage of standard units for each injectable antibiotic 
prescribed in the United states from 2004 to 2014. (Data from the IMS MDART 
Quarterly Database on file at Astrazenca) 23. 
•b-lactams 
• glycopeptides 
• fluoroquinolones 
• maaolides�etolides 
• aminoglycosides 
• polymyxins 
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Figure 2: Developing antibiotic resistance; A timeline of key events 23 
Figure 1 Developing Antibiotic Resistance: 
A Tlmellne of Key Events9 
ANTIBIOTIC RESISTANCE 
IDENTIFIED 
Penlclllln-R Staphylococcus 1940 
Tetracycllne-R Sh/gel/a 1959 
Methlclllln-R Staphylococcus 1962 
Penlclllln-R pneumococcus 1965 
Erythromycln-R Streptococcus 1968 
Gentamlcln-R Enterococcus 1979 
Ceftazldlme-R Enterobacterlaceae 1987 
Vancomycln-R Enterococcus 1988 
Levofloxacln-R pneumococcus 1996 
lmlpenem-R Enterobacteriaceae 
XOR tuberculosis 
Linezolld-R Staphylococcus 
Vancomycln-R Staphylococcus 
POR-Acinetobacter and Pseudotnonas 
1998 
2000 
2001 
2002 
2004/5 
Ceftriaxone-R Nelsserla gonorrhoeae 2009 
POR-Enterobacterlaceae 
Ceftarollne-R Staphylococcus 2011 
ANTIBIOTIC 
INTRODUCED 
1943 Penicillin 
1950 Tetracycline 
1953 Erythromycln 
1960 Methlclllln 
1967 Gentamicln 
1972 Vancomycln 
1985 lmlpenem and 
ceftazldlme 
2000 Linezolld 
2003 Oaptomycln 
2010 Ceftaroline 
POR = pan-drug-resistant: R = resistant: XOR = extensively drug-resistant 
Dates are based upon early reports of resistance In the literature. 
In the case of pan-drug-resistant Aclnetobacter and Pseudornonas. 
the date Is based upon reports of health care transmission or 
outbreaks. Note: penicillin was in limited use prior to widespread 
population usage In 1943. 
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1 .3 Mechanism of beta-lactam 
Figure3. Diagrammatic mechanism of beta-lactam drug 
Since beta-lactam class drugs are prescribed in high frequency and used routinely as first 
line antibiotic for infect ious diseases, resistance to beta-lactam class drugs poses a 
significant challenge to human health. The first Beta-lactamase (bla) was recognized in 
Escherichia coli by E.P. Abraham and E.  Chain and named as "penicillinase. Penicillinase 
was discovered when even the clinical use of penicillin had not been started and the 
enzyme was not considered to be clinically relevant at the time[27-29,30]. Four years of 
continuous work lead Kirby to extract these cell-free "penicillin inactivators" from 
Staphylococcus aureus, which is a significant opportunistic pathogen and he is the first 
scientist to do it [30]. 
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Beta-lactamase is considered one of the major causes for resistance to large valuable 
selections of antibacterial agents. It is a group of enzymes formed by various bacterial cells 
to inactivate beta-lactam antibiotics by destroying the beta-lactam ring structure[figure 4]. 
There are more than 1 ,300 beta-lactamases occurring naturally, which make them perhaps 
one of the largest 1 5  enzyme families that has been studied. In many clinical treatment 
regimens beta-lactam class of antibiotics, such as cephalosporins and carbapenems, are 
used to treat serious infect ions. The capability of beta-lactamases to inactivate this large 
array of antibiotics makes them a real threat to public health [31-32]. 
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Figure 4: Cleavage of beta-lactamase 
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There are many mechanisms that bacteria became resistant to beta-lactam, 
among several others four primary mechanisms occurs most frequently[32]. The 
very first mechanism is bacteria can produce lactamase enzymes itself. It is very 
common and significant mechanism of resistance especially in Gram-negative 
bacteria. Second, by lowering the affinity for beta lactam-antibiotics in which 
changes can occur in the active site of PBPs. Third, bacteria can decrease the 
expression of outer membrane proteins (OMPs). Finally, the multidrug resistant 
occur when efflux pumps can prevent beta-lactam antibiotics to enter the cell or 
throw them out of the cell (34]. 
Specifically, in wastewater, there are mainly three lateral gene transfer mechanisms in 
spreading the beta-lactam antibiotic resistant genes. {I) Conjugation, {II) transformative 
uptake of chromosomal DNA fragments or plasmids; (Ill) Transduction mediated by 
phages [Figure S]. Once the gene is received and combined, the bacterium can produce 
beta lactamase and becomes resistant to beta-lactam drugs. Furthermore, once after the 
treatment the wastewater sample is released back into the environment, if the different 
resistant variants can persist throughout the treatment, it will then travel with water to 
other hosts, where different plants and animals are exposed with it and might occur 
resistant gene directly and indirectly [35]. 
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Figure 5: Three main mechanism of transfer of resistant gene[23] 
1 .4 Classification of beta-lactamase 
In 199 1 ,  Bush and Medeiros classified the beta-lactamases which is the most 
common method of classification. Bush's classification is based on the molecular 
structure of the enzymes in the earlier system . Another scientists Ambler, 
classified beta-lactamases based on conserved and distinguishing amino acid 
motifs. This classification is famous and widely used classification introduced in 
1991 .  Both of their classification aref1 being shown in the Table . 
1 1  
Table 1: Classification of lactamase based on Amber and Bush [36-37] 
(/) a. Characteristics of beta lactamase 
(/) ::l -m e 0 (/) u O> L.. Q) L.. a> E Q) ..c. .0 >. .0 (/) EN E ::l co ::l c < z Q) 
A 2a Staphylococcal and enterococcal 23 
penicillinases 
2b Broad spectrum betalactamases 16 
including TEM-1 and SHV-1, 
mainly occurring in gram-
negatives 
2be Extended spectrum 200 
betalactamases (ESBL) 
2br Inhibitor-resistant TEM (IRT) 24 
betalactamases 
2c Carbenicillin-hydrolysing 19 
enzymes 
2d Cloxacillin (oxacillin) hydrolysing 31 
enzymes 
2e Cephalosporinases inhibited by 20 
clavulanic acid 
2f Carbapenem-hydrolysing enzyme 4 
inhibited by clavulanic acid 
B 3 Metallo-enzymes that hydrolyse 24 
carbapenems and other 
betalactams except 
monobactams. Not inhibited by 
clavulanic acid 
c 1 Often chromosomal enzymes in 51 
gram-negatives but some are 
Plasmid-coded. Not inhibited by 
clavulanic acid. 
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D 4 Miscellaneous enzymes that do 9 
not fit into other groups 
Based on the homology and clinical importance, beta-lactamases can also be 
classified into different families[Table 2). Major families of J3-lactamases of clinical 
importance include: KPC, TEM, SHV, AMPC, CTX-M, PER, VEB, GES, and 
CMY[34-37] . SHVfamily is thought to be primarily derived from Klebsiella spp. and 
TEM was firstly found in E. coli isolates. These gene families can now be found in 
multiple enterobacteria species creat ing a significant threat to treatment (36-28). 
The b/aTEM gene is also one of the most frequently detected plasmid-borne 
antimicrobial resistance genes, which confers resistance to penicillin's and 
extended-spectrum cephalosporins (39). 
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Table 2:  Major families of beta lactamase based on clinical importance 
Enzyme Families Functional group 
CMY 1, 1e 
TEM 2b, 2be, 2br, 2ber 
2b 
2be 
2br 
2ber 
SHV 2b,2be,2ber 
2b 
2be 
2ber 
CTX-M 2be 
PER 2be 
VEB 2be 
GES 2f 
KPC 2f 
SME 2f 
OXA 2d,2de,2df 
2d 
2de 
2df 
IMP 3a 
No of enzymes b,c 
50 
172 
12 
79 
36 
127 
30 
37 
5 
90 
5 
7 
15 d 
9 
3 
158 
5 
9 
48e 
26 
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Representative 
enzymes 
CMY-1 to CMY-50 
TEM-1, TEM-2, TEM-13 
TEM-3, TEM-10, TEM-
26 
TEM-30 (IRT-2), TEM-
31 (IRT-1), TEM-163 
TEM-50 (CMT-1 ), TEM-
158 (CMT-9) 
SHV-1, SHV-11, SHV-
89 
SHV-2, SHV-3, SHV-
115 
SHV-10, SHV-72 
SHV-1, SHV-11, SHV-
89 
PER-1 to PER-5 
VEB-1 to VEB-7 
GES-2 to GES-7 (IBC-1) 
to GES-15 
KPC-2 to KPC-10 
SME-1, SME-2, SME-3 
OXA-1, OXA-2, OXA-10 
OXA-11, OXA-14, OXA-
15 
OXA-23 (ARl-1 ), OXA-
51, OXA-58 
IMP-1 to IMP-26 
VIP 
IND 
3a 23 
3a 8 
a Enzyme families based on primary amino acid structures (G. Jacoby and K. Bush, 
http://www. la hey .org/Studies/). 
bCompiled through December 2009. 
C'fhe sum of the subgroups in each family. 
dGES-1, unlike other members of the GES family, interaction with imepenem 
9Nine clusters of OXA carbapenem 
2.  Objective of the Study 
VIM-1 to VIM-23 
IND-1, IND-2, IND-2a, 
IND-3 to IND-7 
This study collected samples from Charleston wastewater treatment plant and 
nearby upstream and downstream flowing water. In reference to 2010 census the 
population of the city is 2 1 ,838. The aim of the study was to examine the four of 
the beta-lactamase loci in wastewater and stream sources using PCR with 
appropriate positive and negative controls. 
3. Methods and materials 
3.1 Sample collection 
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Figure 6: Sample collection site, source; google map 
I I  1 1 1  IV 
Figure 7. Different sampling point:(I) influx; (II); (Ill) influx bottle and (IV) efflux bottle 
Table 3. Sample collection site, wastewater treatment plant and Cassell Creek 
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Colle Charleston Waste water treatment plant (CWWTP) Untreated Cassell 
ction 
Site Creek 
Sam 
pie's Q) Q) Q) Q) Q) Q) Q) Q) Q) Q) a. a. a. a. a. a. a. a. a. a. 
No E E E E E E E E E E co co co co co co co co co co en ..- en N en (\") en ..q- en LC') en co en en en en 
Date 02/23/ 02/28/ 03/05/ 3/22/2 04/05/ 04/12/ 04/17/2 04/12/2 
2018 2018 2018 018 2018 2018 017 018 
Site E Cl> E Cl> 'O .... .... c ro iii ro �E x x x x x x x x x x x Cl> � 0 .... c: :::> :::> :::> :::> :::> :::> :::> () ::::i :::> ::::i :::> iii � iii � ro c;::: E c;:: E c;::: E c;:: Q) c;::: E «;:: E a. 0 a. 0 c w c w c w c en c w c w ::> 0 ::> 0 
Volu 1 
me 0 10 10 E E E E E E E E E E E E 100 0 00 00 0 0 0 0 0 0 0 0 0 0 0 0 Oml 0 ml ml 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 m 
..- N ..- N ..- N ..- N ..- N ..- N I 
Filtra 
ti on E E E E E E E E E 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 z ....- z ....- z ..- z z z ....- z ....- LO LO LO LC') 
Centrif 
ugation E E E E E E E E E E 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 LC') LC') LC') LC') LO LC') 0 0 0 0 N z N z N z N z N z N z LC') LC') LC') LO 
3.2 Procedures 
3.2 . 1 .  Filtration 
Efflux sample, upstream and downstream sample was filtered. Filtration was 
performed using sterile 47-mm diameter nitrocellulose filters (NALGENE® Nalge 
Nunc International, USA) with pore size of 0.22 µm. 1 00ml of sample was filtered 
at once and collected in single tube with sterile water by using the sterile spatula 
with scraping. In the second phase of sample collection filter disc were cut into 
pieces and processed for further examinations. 
3.2.2 Centrifugation 
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Once the sample was were collected, it was processed immediately. Influx sample 
was centrifuge 250ml each in 4 plastic bottles at 44 72xg for 1 5  min (Sorvall RC-
5B Superspeed Centrifuge). After centrifugation , s upernatant was removed and 
mixed in one bottle then distributed in tubes (1.5ml) which were then again 
centrifuged for 1 7,000xg for 20 minutes. After that, s upernatant liquid was 
discarded, and solids were combined to reduce the total number of the tubes for 
the next procedure. 
3.2.3 Bead beating and E.Coli Controls 
In sample year 201 8  four rounds the sample collected was processed with the 
bead beating tubes provided with Fast DNAR spin kit for soil (MP Biomedicals, 
USA) in mini-bead beater-16  (BioSpace Products, USA) but no difference was 
observed in the quality of the DNA. So, after that bead beating was done for five 
minutes for each sample and E. coli controls were kept. Bead beating was done 
as suggested by manufacture's instruction fast DNATM spin kit for soil (MP 
Biomedicals, USA). 
Table 4. Time Variation in bead beating 
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Samples Tubes Labelled Time variation each tube 
(Minute) 
Sample 1 Influx 1 1  5 
12 9 
13 1 2  
Sample 2 Efflux E1  5 
E2 9 
E3 12 
Sample 3 Influx 1 1 a  5 
12a 10  
13a 1 5  
Sample 4 Efflux E1a 5 
C:"),.. 1 n 
3.2.4 Genomic DNA extraction 
Following bead-beating, al l samples were processed following manufacturers' 
protocols according to each respective extract ion kit. The total volume of eluted 
DNA was 1 00 µL  from each single bead beating tube. All the collected sample in 
sample year 2018 were further cleaned up using GeneClean II kit (MP 
Biomedicals, USA). 
3.2.5 Controls 
Purified E. coli strain ATCC 25922 DNA was used as a positive control for all 1 6s 
rDNA PCR reactions. Positive controls for bla variants were obtained from BEi 
Resources (Table 9). 
3.2.6 Quant ificat ion 
All the extracted DNA from the samples were quant ified by using Epoch TM 2 
Microplate Spectrophotometer (BioTek, USA). 2 µL Extracted DNA samples were 
taken for all quantification tests. Gen5 software was used for this procedure. 
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3.2. 7 Polymerase chain reaction (PCR) 
BioRad MyCycler PCR (Hercules, USA) and Biometra T-Gradient Thermal Cycler 
PCR (Gott ingen, Germany) were used in all the PCR reactions. Bacterial DNA 
were first detected by universal 1 6s rDNA fragments and different primers set were 
used to amplify the selected genes. The primers for the 16S rDNA were 47F and 
0691 R primers (Table 5). Primers for bla loci are listed in Table 6. All react ions 
were carried out using Taq 2X Master Mix (New England Biolab, USA) following 
the manufacturer's protocols. Each primer was added at 1 0  pmol per reaction. 
PCR cycles and conditions are shown in Tables 7 & 8. 
Table 5. 1 6S Universal primers used in this study and sequences. 
Primer Sequence (5'-3') Reference 
47F C 47F C [40] 
GAGTTTGATCCTGGCTCAG GAGTTTGATCCTGGCTCAG 
069 1 R  069 1 R  [40] 
GCATTACARGATTTCAC GCATTACARGATTTCAC 
Table 6. bla primers used in this study sequences. 
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Primer Sequence (5'-3') Reference 
b/aKPC For: ATGTCACTGTATCGCCGTC [40] 
Rev: TT ACTGCCCGTT AACGCC 
b/aSHV For: ATTTGTCGCTTCTTT ACTCGC [40] 
Rev: 
TTTATGGCGTTACCTTTGACC 
b/aTEM For: [40] 
AGACGTCAGGTGGCACTTTTCGG 
Rev: CAAGGGGTCTGACGCTCA 
b/aKPC For: ATCAAAACTGGCAGCCG [40] 
Rev: 
GAGCCCGTTTTATGGACCCA 
Table 7. PCR time and conditions for 16s rDNA amplifications 
Primer sets 
47F 
1 492 R(Long) 
47F 
069 1 R(short) 
Initial 
Denaturation 
(0 c)/Time 
96° I 5 mins 
96° I 5 mins 
Amplifications conditions 
Melting 
(0 
c)/Time 
96° I 30 
sec x 35 
cycle 
96° I 30 
sec x 35 
cycle 
Annealing 
(0 c)/Time 
49° I 20 
sec x 35 
cycle 
48° I 20 
sec x 35 
cycle 
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Extension 
(0 c)/Time 
72° I 1 min 
30 sec x 
35 cycle 
72° I 45 
sec x 35 
cycle 
Final 
extension 
(0 c)/Time 
72° I 4 
mins 
72° I 2 
min 1 5  
sec 
Hold 
(o c) 
40 
40 
Table 8. PCR time and conditions for b/a amplifications 
Primers Amplificat ions conditions 
sets 
blaKPC 
blaTEM 
blaSHV 
blaAMPca 
Initial 
Denaturation 
(0 c)/Time 
94° I 1 min 
94°I 1 min 
Melting 
(0 
c)/Time 
96° I 
30 sec 
x 35 
cycle 
96°/ 
30 sec 
x 35 
cycle 
3.2.8 Agarose gel electrophoresis 
Annealing 
(0 c)/Time 
59.5° I 30 
sec x 35 
cycle 
56° I 30 
sec x 35 
cycle 
Extension 
(0 c)/Time 
72° I 60 
sec 2 x 
35 cycle 
72° I 30 
sec 45 
sec x 35 
cycle 
Final Hold 
extension (o c) 
(0 
c)/Time 
72° I 3 40 
mins 
72° I 3 40 
mins 1 5  
sec 
Agarose gels (0.8% or 1 .4% (w/v)) were prepared in 1 x  TBE buffer supplemented 
with GelRed. Electrophoresis was conducted at 95-1 10  mV for 1-3 hours. Results 
were viewed with UV illumination, photographed using a Gel Doc XR+ system, 
then analyzed by Image Lab 3.0 software (BioRad Laboratories, Inc., Hercules, 
CA, USA). 
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Table 9. Positive control strain for b/a variants 
Strain Description Reference 
NR-16464 Klebsiella pneumoniae [40] 
isolate 1 
NR-1 6465 Klebsiella pneumoniae [40] 
isolate 2 
NR-16466 Klebsiella pneumoniae [40] 
isolate 3 
NR-1 6470 Klebsiella pneumoniae [40] 
isolate 7 
NR-16471 Klebsiella pneumoniae [40] 
isolate 8 
4. Results 
4.1  DNA extraction 
WWTP water samples, upstream and downstream water samples were collected 
and processed as described in Methods and Material section. After the sample 
collection DNA was extracted from fast DNA spinkit for Soil miniprep from MP 
Biomedicals. This is continued research from previous year so, previously we had 
used different kit to extract the DNA and figured out MP biomedical kit was good 
for this kind of environmental sample for extraction. In the process time duration 
were varied in each sample of bead beating to check the qual ity of DNA[Table 4). 
Stock E. coli solutions were added, to control for the ability of the kits to obtain 
bacterial DNA, and the solutions were added to select samples prior to processing. 
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After the purification with the MP Fast DNA Spin kit, samples were further purified 
using GeneClean II system from MP Biomedicals to remove putative chemical 
inhibitors for PCR reactions. DNA samples were then quantified as described 
(Table 1 0). The 260/280 ratio was also obtained to assess the purity of the DNA 
samples. In general, influx samples yielded higher amounts of total DNA. The 
duration of bead beating did not make significant changes in the quantity of DNA 
retrieved, nor did it make a significant change in the purity ratio. 
4.2. PCR Results 
4.2.1 Bacterial 1 6s rDNA detection 
In wastewater besides bacteria there are many other organisms. The presence of 
total DNA of good quality is not enough indication that they are suitable for PCR 
based assay. Therefore, as a control to show that DNA samples we extracted 
contain bacterial chromosomal DNA, the 16s rDNA universal primers were used. 
Short pair of 1 6S fragment were used as control reactions for the presence of 
bacterial samples (Figures 1 0). Successful amplification of the 16S pair fragments 
indicates that there are detectable levels of bacterial chromosomes in the extracted 
total DNA of a preparation. 
In the beginning certain extract ion methods PCR amplification were failed in 1 6Sr 
DNA so we used the additions of positive E. Coli to the environmental DNA 
samples (Figure 8). The results showed that the same amount and type of DNA 
that can produce successful 1 6S amplification on its own did not lead to detectable 
PCR products when added to the environmental DNA samples extracted using 
either the e ZR-Duet DNA/RNA miniprep or the Fecal DNA Sample miniprep kit 
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but after using Fast DNA spin kit for soil(MP Biomedicals, USA) we are able to 
successfully amplify the 16s rDNA. 
PsS 
L C2 
644 l 
Figure 8. Detection of the short pair of 1 68 rDNA gene coding for the beta­
lactamase in DNA isolated form different waste water sample. E1 and E2 are 
efflux sample and C2 is the E .  Coli positive Control. 
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Table 10. DNA quantification of waste water and untreated upstream 
Sample Labelled DNA 260/280 
tube concentration( ng/µI) ratio 
Klebsiella 
Pneumoniae 
control 
Sample 1 11a 1 84.83 1 .54 
Influx 
11b 95.92 1 .81 
11c 88.99 1 .76 
Sample 2: E 1 a  1 40.23 1.93 
Efflux 
E 1 b  110.57 1.93 
E1c  97.31 1 .88 
E1d  210.32 1.77 
Sample 3: 12a 92.53 1.40 
Influx 
12b 65.50 1.81 
Sample E2a 1 30.63 1.54 
4:Efflux 
E2b 92.18 1.33 
Samples: U1a 21.18 2.60 
Upstream 
U1b 1 8.42 2.11 
Sample6: D2a 32.49 3.14 
Downstream 
D2b 42.32 2.28 
D2c 26.61 2.21 
Based on the 260/280 ratio so we use 100 ng/µI as standard to calculate our 
genomic DNA and based on these calculations we have set up our PCR reaction. 
In addition to the 260/280 ratio, which reveals the amount of protein carry over in 
the DNA preparation, the quality of the total DNA samples was also assessed 
using agarose gel electrophoresis. 
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4 3 2 1 L 
4 3000 bp 
+-11200bp 
4 1000 bp t t 
-+--+ 500 bp 
+--7- 100 bp 
Figure 9.  Detection of 4 different bla variants control, Lane l is the DNA size marker, 
lane 1 is the b/aSHV gene with 1100 bp, lane 2 is b/aKPC gene with lane size 890bp, 
lane 3 is b/aTEM gene with lane 1150 bp and 4 is b/aAmpC gene with lane 800bp size. 
Position of each bla gene is indicated arrow. 
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+--100 bp 
Figure 10. Detection of the 16s rDNA gene coding for the beta-lactamase in DNA 
isolated from different waste water samples. lane l: DNA size marker; Lane 1: 
Positive control; Lane 2: Negative control; Lane 3 & 4: influent source(644bp); Lane 
5 & 6: tertiary tank source. Position of the 16s rDNA gene is indicated by red arrow. 
4.2.2 bla variants detection 
bla variants were detected and protocol was carried out as described in Methods 
and Material, with positive control DNA obtained from the BEi Resource Center. 
The four variants of bla were each assayed in separate PCR reactions using 
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different samples from collection sites. The sample was collected from influx, 
efflux, tertiary tank, downstream water and upstream water. 
All four variants b/aKPC, b/aTEM, b/aSHV and b/aTEM were detected in influx and 
tertiary tank samples, whereas none of the efflux or stream water samples showed 
positive outcomes (Figures 1 1 -14). In the sample year 2017 For variant b/aTEM, 
two of the four wastewater samples showed a positive amplification while none of 
the influx or stream water samples did . The PCR results of 16s rDNA and b/a 
variants from 2017-2018 is summarized in Table11a  and 1 1 b. 
3000 bp 
1200 bp 
1000 bp 
SOO bp 
Figure 1 1 .  Detection of the b/aAmpC gene coding for the beta-lactamase in DNA 
isolated from different waste water samples. Lane L: DNA size marker; Lane 1 :  
Positive control; Lane 2: Negative control; Lane 3-6: influent source(780bp); 
Lane 7 & 8: effluent source. Position of the blaAmpC is indicated by arrow. 
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Figure 12.  Detection of the b/aSHV gene coding for the beta-lactamase in DNA 
isolated from different waste water samples. Lane L: DNA size marker; Lane 1 :  
Positive control; Lane 2: Negative control; Lane 3-6: influent source(1 100bp); 
Lane 7 & 8: effluent source. Lane 9-1 1 :  Influent source; Position of the blaSHV 
is indicated by arrow. 
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e 
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-- 3000 bp 
1000 bp 
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Figure 1 3. Detection of the blaTEM gene coding for the beta-lactamase in DNA 
isolated from different waste water samples. Lane L: DNA size marker; Lane 1 :  
Positive control; Lane 2: Negative control; Lane 3-6: influent source(1150bp); 
Lane 7 & 8: effluent source. Position of the blaKTEM is indicated by arrow. 
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Figure 14. Detection of the b/aKPC gene coding for the beta-lactamase in DNA 
isolated from different waste water samples. Lane L: DNA size marker; Lane 1 :  
Positive control; Lane 2: Negative control; Lane 3-6: influent source(890bp); 
Lane 7 & 8: effluent source. Position of the blaKPC is indicated by arrow. 
Table 1 1a. PCR summary; Detection of beta lactamase in sample year-2017 
Samples and bla variants 
control 47F blaKPC blaTEM blaSHV blaAmpc 
0691R 
E. coli + - - - -
Klebsiella + + + + + 
Pneumoniae 
Influx + + + + + 
Efflux + - - - -
Downstream + - - - -
Upstream + - - - -
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Table 1 1  b. PCR summary; Detection of beta lactamase in sample year-2018 
Samples and bla variants 
control 47F blaKPC blaTEM blaSHV blaAmpc 
069 1 R  
E. coli + - - - -
Klebsiella + + + + + 
Pneumoniae 
Influx + + + + + 
Tertiary tank + + + + + 
Efflux + - - - -
5. Discussion 
In the study we used; FastDNA R spin kit for soil, MP Biomedicals which gives the 
good concentration of DNA (Table 1 0) and also amplify the 16s rDNA genes (figure 
1 0). However, in the first phase of sample collection we were not able to extract 
the concentration of DNA[43). Later on, the second phase of sample collection we 
figured it out using the extraction kit from MP Biomedicals using the gene clean kit 
after the PCR process. 
Furthermore, in the first phase of sample collection E. Coli DNA was added to the 
extracted sample as template for PCR, no positive outcomes were detected[43]. 
This result demonstrated that the two extraction kits allowed PCR inhibitors to be 
carried through the samples during processing in the first sample year[43]. 
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This result showed that the purification process managed to remove PCR-inhibiting 
compounds from the samples that the two other kits left behind. For all three DNA 
extraction kits examined[43], the duration of bead-beating did not seem to make a 
significant difference in the outcome, so we did 5 min of bead beating for every 
sample in the second phase of sample processing. In  al l cases, lengthening the 
duration did not cause any observable changes in the quality of DNA samples and 
had no measurable impacts on the success of PCR amplifications. 
5.1 Presence of bla variants in water samples 
Four ARGs b/aTEM, b/aKPC, b/aSHV, b/aAmpC and the 16S rDNA gene were 
amplified using PCR assays on samples collected at the different stages of 
wastewater treatment as well as from fresh water samples. All samples examined 
showed positive outcomes for the 1 6S rDNA amplification, thus confirming the 
presence of detectable levels of bacterial DNA in all samples. Further, PCR control 
amplifications with the 4 primer pairs specific to the 4 bla variants using Klebsiella 
spp. genomic DNA produced PCR amplicons, demonstrating that our PCR primer 
pairs are capable of amplifying the target genes. For wastewater and fresh water 
samples, all four bla variants were detected in influx, and tertiary tank. However, 
these were not detected on downstream and upstream water and efflux samples. 
Since 16S rDNA amplicons were present in all samples, the absence of variant­
specific amplification products in our samples suggested that these genetic 
materials were present at a level that is below detection in those samples. The 
absence of detectable levels of bla variants in the efflux samples showed that 
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water treatment process successfully reduced the level of these DNA loci to a level 
that is below PCR detection. The stream water outcomes also demonstrated that 
these loci are more common in the wastewater influx, and not typically present in 
untreated stream water. 
Although the four loci were no longer detectable at the efflux sample, there is still 
potential hazard in their presence in the influx and up to tertiary tank sample. 
Throughout the wastewater sample processing, solid wastes are removed and 
treated in different ways, such as being used as starting material for anaerobic 
digester. These resistant loci may persist in  those venues. Further examination of 
the wastewater treatment process will be required to fully monitor the potential 
health risks. Also, this study focused on one sample taken at one time during the 
processing. Therefore, the results should not be generalized to reflect the overall 
status of the quality of the wastewater. Further examination of the process 
(different sample sites) with routine sampling is necessary to understand the 
picture fully. There are also other bla genes of importance for human and animal. 
Future research should focus on these gene and the resistance bacteria. Also, the 
next step is that after understanding which organisms carry ARGs, and how mobile 
these genes are, we can make evidence-based conclusions on the risk caused by 
antibiotic resistance in waste waters and the possible mitigation of those risks. By 
saying this a continuous monitoring procedure with regular sampling will be 
required to fully understand the risk of a significant presence of these resistant loci 
in our wastewater samples. 
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